Hypoglycemia adverse events in PICUs and cardiac ICUs: differentiating preventable and nonpreventable events*

Paul L Shea1, Michael C Spaeder, Puneet Sayal

  • 11Department of Pediatrics, Section of Critical Care, St Christopher's Hospital for Children, Philadelphia, PA. 2Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA. 3Department of Critical Care Medicine, Children's National Medical Center, Washington, DC. 4Department of Pediatrics, The George Washington University School of Medicine, Washington, DC. 5Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA.

Insights

Preventable hypoglycemia adverse events are linked to patients receiving only parenteral nutrition. In cardiac intensive care units, events are more likely to be preventable during weekends and holidays.

Area of Science:

  • Pediatric critical care medicine
  • Patient safety
  • Clinical informatics

Background:

  • Hypoglycemia adverse events (AEs) pose risks in pediatric intensive care units (PICUs) and cardiac intensive care units (CICUs).
  • Effective detection and characterization of hypoglycemia AEs are crucial for improving patient safety.
  • Understanding factors contributing to preventable hypoglycemia is key to developing targeted interventions.

Purpose of the Study:

  • To utilize an adverse event detection system to identify, characterize, and categorize preventable versus nonpreventable hypoglycemia AEs.
  • To analyze clinical and demographic variables associated with preventable and nonpreventable hypoglycemia AEs in PICUs and CICUs.

Main Methods:

  • Retrospective observational study design.
  • Analysis of all hypoglycemia triggers generated over a 3-year period in a tertiary pediatric hospital's PICU and cardiac ICU.
  • Investigation of electronic health record-driven surveillance data to classify hypoglycemia events as true AEs and determine preventability.

Main Results:

  • 197 hypoglycemia AEs occurred in 90 patients; 30-36% were preventable.
  • Events were more likely to be preventable in patients receiving sole parenteral nutrition (OR 9.5).
  • In cardiac ICUs, events on weekends/holidays were more likely to be preventable (OR 11.6).

Conclusions:

  • Preventable hypoglycemia AEs are associated with sole parenteral nutrition in PICUs and CICUs.
  • Weekend and holiday timing is linked to preventable hypoglycemia AEs specifically within the cardiac ICU.
  • These findings highlight the need for enhanced surveillance and targeted interventions for hypoglycemia prevention in vulnerable patient populations.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...